Previous 10 | Next 10 |
DELRAY BEACH, Fla., Jan. 28, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, to...
T2 Biosystems (TTOO) -20% despite strong Q4 & FY20 prelims.AIkido Pharma (AIKI) -18%.Seanergy Maritime Holdings (SHIP) -18%.Celsion CLSN -15%.Recon Technology (RCON) -15%.TransEnterix (TRXC) -14% after $69.25M capital raise.Ocugen (OCGN) -14%.BIOLASE (BIOL) -15%.P...
AzurRx BioPharma ([[AZRX]] -7.6%) announces the activation of two additional clinical trial sites in Poland for the extension arm of the Phase 2b OPTION 2 study investigating immediate-release capsules of MS1819 for the treatment of exocrine pancreatic insufficiency ((EPI)) in ...
DELRAY BEACH, Fla., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Az u rRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) di...
4 Penny Stocks to Watch on Today Despite the market starting low in the morning, by midday, many penny stocks were up on January 22nd. There are a lot of factors influencing the stock market today. With lower-priced stocks, volatility continues playing a big role. With so many diffe...
Gainers: AzurRx BioPharma (AZRX) +59%.Climate Change Crisis Real Impact I Acquisition (CLII) +59%.GameStop (GME) +55%.Adamis Pharmaceuticals (ADMP) +41%.111 (YI) +41%.Asia Pacific Wire & Cable (APWC) +37%.Polar Power (POLA) +35%.Electro-Sensors (ELSE) +31%.Mmtec (MTC) +28%.MingZ...
Gainers: Adamis Pharmaceuticals (ADMP) +47%, AzurRx BioPharma (AZRX) +38%, 111 (YI) +27%, Obalon Therapeutics (OBLN) +17%, iBio (IBIO) +17%.Losers: Celsion CLSN -18%, ViewRay VRAY -14%, ADiTx Therapeutics (ADTX) -14%, Passage Bio PASG ...
AzurRx BioPharma (AZRX) announces that the first two patients have been dosed in the Phase 2b OPTION 2 extension study of MS1819 using immediate release capsules for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.The OPTION 2 extension phase design will te...
DELRAY BEACH, Fla., Jan. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, today ...
Patent allowed by the USPTO that includes claims for niclosamide as a treatment for COVID-19 GI infections COVID-19 GI infections are a significant unmet clinical need; AzurRx estimates potential U.S. market size of $450-600 million or greater in first year depending on how quick...
News, Short Squeeze, Breakout and More Instantly...
AzurRx BioPharma Inc. Company Name:
AZRX Stock Symbol:
NASDAQ Market:
AzurRx BioPharma Inc. Website:
BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (G...
Why Investors Are Watching These 3 Penny Stocks Right Now There are plenty of ways to find the best penny stocks to buy right now. And, one method that many penny stocks investors use is looking at what top investors are buying alongside other metrics. While this can be a good strat...
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastroint...